Difference between revisions of "Team:CPU CHINA"

Line 1: Line 1:
 
{{:Team:CPU_CHINA/Templates/NavFoot}}
 
{{:Team:CPU_CHINA/Templates/NavFoot}}
{{:Team:Imperial_College/Templates/Footer}}
 
 
<html>
 
<html>
  
Line 82: Line 81:
  
 
</body>
 
</body>
 +
</html>
 +
 +
<html>
 +
<style>
 +
.footer-distributed{
 +
background-color: #F7F5E6;
 +
box-shadow: 0 1px 1px 0 rgba(0, 0, 0, 0.12);
 +
box-sizing: border-box;
 +
width: 100%;
 +
text-align: left;
 +
padding: 45px 50px;
 +
margin-top: 80px;
 +
}
 +
 +
.footer-distributed .footer-left p{
 +
        color:  #52658F;
 +
font-size: 14px;
 +
margin: 0;
 +
}
 +
.footer-distributed .footer-right p{
 +
        color:  #52658F;
 +
font-size: 14px;
 +
margin: 0;
 +
}
 +
 +
/* Footer links */
 +
 +
.footer-distributed p.footer-links{
 +
font-size:18px;
 +
font-weight: bold;
 +
color:  #ffffff;
 +
margin: 0 0 10px;
 +
padding: 0;
 +
}
 +
 +
 +
.footer-distributed p.footer-links a{
 +
display:inline-block;
 +
line-height: 1.8;
 +
text-decoration: none;
 +
color:  inherit;
 +
}
 +
 +
.footer-distributed .footer-right{
 +
float: right;
 +
margin-top: 6px;
 +
max-width: 400px;
 +
}
 +
 +
 +
 +
.footer-distributed .footer-right a{
 +
display: inline-block;
 +
width: 50px;
 +
height: 35px;
 +
background-color:  #33383b;
 +
border-radius: 2px;
 +
 +
font-size: 20px;
 +
color: #52658F;
 +
text-align: center;
 +
line-height: 35px;
 +
 +
margin-left: 3px;
 +
}
 +
 +
.sponsors {
 +
            margin: 2.5px;
 +
            width: 125px;
 +
        }
 +
 +
/* If you don't want the footer to be responsive, remove these media queries */
 +
 +
@media (max-width: 600px) {
 +
 +
.footer-distributed .footer-left,
 +
.footer-distributed .footer-right{
 +
text-align: center;
 +
}
 +
 +
.footer-distributed .footer-right{
 +
float: none;
 +
margin: 0 auto 20px;
 +
}
 +
 +
.footer-distributed .footer-left p.footer-links{
 +
line-height: 1.8;
 +
}
 +
}
 +
</style>
 +
 +
<footer class="footer-distributed">
 +
 +
<div class="footer-right">
 +
                <a target="_blank" href="mailto:igem.imperial2016@gmail.com"><i class="fa fa-envelope-o fa-2x"></i></a> 
 +
    <a target="_blank" href="https://www.facebook.com/2016imperialigem/"><i class="fa fa-facebook fa-2x"></i></a>
 +
<a target="_blank" href="https://twitter.com/imperialigem"><i class="fa fa-twitter fa-2x"></i></a>
 +
<a target="_blank" href="https://github.com/IC-iGEM-2016?tab=repositories"><i class="fa fa-github fa-2x fa-fw"></i></a>
 +
<p> Email: igem.imperial2016@gmail.com </p>
 +
</div>
 +
 +
 +
<div class="footer-left">
 +
 +
<p class="footer-links">
 +
<a target="_blank" href="https://www.imperial.ac.uk/synthetic-biology">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/6/68/T--Imperial_College--csynbi.png">
 +
    </a>
 +
 +
<a target="_blank" href="http://www.synbicite.com/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/1/1c/T--Imperial_College--synb.png">
 +
    </a>
 +
 +
<a target="_blank" href="https://www.neb.com/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/e/ed/T--Imperial_College--NEB.png">
 +
    </a>
 +
<a target="_blank" href="https://www.sebiology.org/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/5/5e/T--Imperial_College--SEB.png">
 +
    </a>
 +
                             
 +
                                        <a target="_blank" href="https://wellcome.ac.uk/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/b/b5/T--Imperial_College--Wellcom.png">
 +
    </a> 
 +
 +
            <a target="_blank" href="https://www.epsrc.ac.uk/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/d/d9/T--Imperial_College--EPSRC.jpg">
 +
    </a>
 +
<a target="_blank" href="http://www.bbsrc.ac.uk/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/1/1e/T--Imperial_College--BBSRC.gif">
 +
    </a>
 +
<a target="_blank" href="https://www.eppendorf.com/UK-en/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/3/3a/T--Imperial_College--Eppendorf.png">
 +
    </a>
 +
 +
<a target="_blank" href="http://www.bmglabtech.com/">
 +
        <img class="sponsors" src="https://static.igem.org/mediawiki/2016/e/ee/T--Imperial_College--BMG.png">
 +
    </a>
 +
 +
</p>
 +
 +
 +
</div>
 +
 +
</footer>
 +
 +
 
</html>
 
</html>

Revision as of 00:27, 30 October 2017

SynNotch CAR-Tregs V.S. Rheumatoid Arthritis

HEAD-Treg

Description

Rheumatoid arthritis (RA) is a serious chronic, inflammatory and systemic autoimmune disease.

s of great essence to develop a kind of novel cell-targeted therapy for RA because there is no radical cure for RA for the time being.

To solve the problems existing in the current treatment of RA, we design and build a brand new immunotherapy. FOXP3+ regulatory T cells(Tregs), which can suppress and regulate immune reactions, are modified utilizing a lentiviral vector system to express a chimeric antigen receptor(CAR) targeting inflammatory cells associated with RA.

Meanwhile, we insert the Syn-Notch receptor to activate the functional stability pathway of Tregs in the inflammatory environment, which enables them to play their role of immunosuppression in lesions more efficiently and more stably.

These two redirections of the two different but interrelated systems on Tregs ensure this novel therapy a promising anti-RA effect.